KAPIL D. SETHI, MD
Neurology at 15 St, Augusta, GA
License number
Georgia 027303
Category
Neurology
Type
Neurology
Address
Address
1120 15Th St, Augusta, GA 30912
Phone
(706) 721-4581
(706) 721-6757 (Fax)
(706) 828-6410
(706) 721-6757 (Fax)
(706) 828-6410
Organization information
See more information about KAPIL D. SETHI at bizstanding.comKapil D Sethi MD
1120 15 St #ST340, Augusta, GA 30912
Categories:
Neurology Physicians & Surgeons
Phone:
(706) 721-2798 (Phone)
Kapil D Sethi MD
1429 Harper St, Augusta, GA 30912
Categories:
Neurology Physicians & Surgeons
Phone:
(706) 721-4670 (Phone)
Professional information
Dr. Kapil D Sethi, Augusta GA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Georgia Regents Med Ctr Nrlgy
1447 Harper St, Augusta 30912
(706) 721-4581 (Phone)
1447 Harper St, Augusta 30912
(706) 721-4581 (Phone)
Certifications:
Neurology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
PUNJAB UNIVERSITY / CHRISTIAN MEDICAL COLLEGE
Christian Med Coll
Medical College of Georgia Hospital and Clinic
Pgimer
PUNJAB UNIVERSITY / CHRISTIAN MEDICAL COLLEGE
Christian Med Coll
Medical College of Georgia Hospital and Clinic
Pgimer
Method Of Treatment Or Prophylaxis Of Restless Legs Syndrome With Ropinirole Compound
US Patent:
2003015, Aug 14, 2003
Filed:
Feb 10, 2003
Appl. No.:
10/361252
Inventors:
Kapil Sethi - Augusta GA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K031/405
US Classification:
514/418000
Abstract:
The present invention provides a method of treating Restless Legs Syndrome in human or animal patient, which method comprises administering to said patient an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof. Preferably, a dose of ropinirole or a pharmaceutically acceptable salt or solvate thereof is administered to the patient 1 to 3 hours before the patient goes to bed. A typical dose comprises 0.1 mg -5 mg of ropinirole. The invention also provides a pharmaceutical composition for use in the treatment of Restless Legs Syndrome which comprises an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable carrier.
Method Of Treatment Or Prophylaxis
US Patent:
2001002, Oct 11, 2001
Filed:
Jun 12, 2001
Appl. No.:
09/879462
Inventors:
Kapil Sethi - Augusta GA, US
International Classification:
A61K031/404
US Classification:
514/418000
Abstract:
The present invention provides a method of treating Restless Legs Syndrome in human or animal patient, which method comprises administering to said patient an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof. Preferably, a dose of ropinirole or a pharmaceutically acceptable salt or solvate thereof is administered to the patient 1 to 3 hours before the patient goes to bed. A typical dose comprises 0.1 mg-5 mg of ropinirole. The invention also provides a pharmaceutical composition for use in the treatment of Restless Legs Syndrome which comprises an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable carrier.
Method Of Treatment Or Prophylaxis
US Patent:
2004015, Aug 12, 2004
Filed:
Dec 18, 2003
Appl. No.:
10/740081
Inventors:
Kapil Sethi - Augusta GA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K031/404
US Classification:
514/418000
Abstract:
The present invention provides a method of treating Restless Legs Syndrome in human or animal patient, which method comprises administering to said patient an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof. Preferably, a dose of ropinirole or a pharmaceutically acceptable salt or solvate thereof is administered to the patient 1 to 3 hours before the patient goes to bed. A typical dose comprises 0.1 mg-5 mg of ropinirole. The invention also provides a pharmaceutical composition for use in the treatment of Restless Legs Syndrome which comprises an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable carrier.
Method Of Treatment Or Prophylaxis
US Patent:
2002010, Aug 1, 2002
Filed:
Mar 22, 2002
Appl. No.:
10/105118
Inventors:
Kapil Sethi - Augusta GA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K031/404
US Classification:
514/421000
Abstract:
The present invention provides a method of treating Restless Legs Syndrome in human or animal patient, which method comprises administering to said patient an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof. Preferably, a dose of ropinirole or a pharmaceutically acceptable salt or solvate thereof is administered to the patient 1 to 3 hours before the patient goes to bed. A typical dose comprises 0.1 mg-5 mg of ropinirole. The invention also provides a pharmaceutical composition for use in the treatment of Restless Legs Syndrome which comprises an effective amount of ropinirole or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable carrier.